St. Jude Medical (STJ) : The consensus on St. Jude Medical (STJ) based on 21 analyst recommendation on the company stock is 2.71, which is interpreted as a Hold recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 3 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 18 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
St. Jude Medical (STJ) : The highest level St. Jude Medical (STJ) is projected to reach is $91 for the short term and the lowest estimate is at $54. The consolidated price target from 18 rating analysts who initiate coverage on the stock is $73.81 and the possibility the share price can swing is $11.55.
St. Jude Medical (NYSE:STJ): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $78.03 and $77.93 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $79.50. The buying momentum continued till the end and the stock did not give up its gains. It closed at $79.43, notching a gain of 1.66% for the day. The total traded volume was 1,912,355 . The stock had closed at $78.13 on the previous day.
Also, In a research note released to the investors, Barclays downgrades its rating on St. Jude Medical (NYSE:STJ).The analysts at the brokerage house have a current rating of Equal-weight on the shares. Earlier, the shares were rated a Overweight by the brokerage firm. In a recent information released to the investors, Barclays raises the new price target from $74 per share to $80 per share. The rating by the firm was issued on May 11, 2016. The company shares have rallied 6.03% from its 1 Year high price. On Jul 21, 2015, the shares registered one year high at $80.84 and the one year low was seen on Feb 11, 2016. The 50-Day Moving Average price is $77.34 and the 200 Day Moving Average price is recorded at $63.23.
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).